Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots of the Study Details page for NCT03029598. The content and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T20:53:55.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    Upgrade notice added about funding and operations; version updated to v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T07:57:23.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Removed detailed neoplasm and carcinoma terms and added a new revision tag: v3.1.0. This suggests a simplification or renaming of content with an updated version rather than adding substantive new material.
    Difference
    0.5%
    Check dated 2025-09-29T04:23:04.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added: Revision v3.0.2; Removed: Revision v3.0.1 and Back to Top. No changes to core content, pricing, or stock.
    Difference
    0.1%
    Check dated 2025-09-14T22:09:13.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T19:19:04.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new medical terms and conditions related to ovarian cancer and other diseases, while removing previous references to specific locations and certain genetic resources.
    Difference
    3%
    Check dated 2025-08-31T12:30:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.